Cancer research finds targets for new cholesterol-lowering therapies

" A team of investigators from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) and Harvard Medical School has uncovered novel targets for the development of drugs that would potentially complement, or replace, statins in treating heart disease. "

Cancer research finds targets for new cholesterol-lowering therapies